Clinical Trial Update: Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumor, or aty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Medulloblastoma
• Supratentorial Primitive Neuroectodermal Tumor

Drugs mentioned

• Eloxatin (oxaliplatin)

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED